RenovoRX
  • Media
  • Careers
  • Investors
  • About
    • Leadership Team
    • Board of Directors
    • Advisory Board
  • Clinical Trials
    • About TIGeR-PaC
    • TIGeR-PaC
      Candidate Criteria
    • TIGeR-PaC Participating
      Clinical Sites
  • Our Therapy Platform
  • Pipeline Overview
  • Clinicians
  • Contact
  • About
    • Leadership Team
    • Board of Directors
    • Advisory Board
  • Clinical Trials
    • About TIGeR-PaC
    • TIGeR-PaC
      Candidate Criteria
    • TIGeR-PaC Participating
      Clinical Sites
  • Our Therapy Platform
  • Pipeline Overview
  • Clinicians
  • News
  • Careers
  • Investors
  • Contact
Investors

Investors

  • Overview
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • News & Events
    • Overview
    • Press Releases
    • Clinical News
    • IR Calendar Events
    • Email Alerts
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

  • News & Events

  • Overview
  • Press Releases
  • Clinical News
  • IR Calendar Events
  • Email Alerts
Jul 08, 2024 8:30am EDT

RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist®

Jun 26, 2024 8:30am EDT

University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial

Jun 10, 2024 8:30am EDT

RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships

May 30, 2024 8:30am EDT

RenovoRx CEO Issues Update Letter to Shareholders

May 21, 2024 9:00am EDT

Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted Cancer Drug Treatment Delivery

May 14, 2024 9:00am EDT

RenovoRx to Participate in Fireside Chat at the A.G.P. Virtual Healthcare Company Showcase on May 21, 2024

May 02, 2024 9:00am EDT

RenovoRx CEO Shaun R. Bagai to Present at the Aegis Capital Virtual Conference on May 9, 2024

Apr 18, 2024 8:30am EDT

RenovoRx Regains Compliance with Nasdaq Stockholders’ Equity Requirement

Apr 16, 2024 8:30am EDT

RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting

Apr 15, 2024 8:00am EDT

RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 13
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

2570 W. El Camino Real, Suite 320
Mountain View, CA 94040

(650) 284-4433

(650) 397-4433

RenovoRX

Delivering Therapy Where it Matters

Quicklinks
  • About
  • Clinical Trials
  • Our Therapy Platform
  • Pipeline Overview
  • Clinicians
  • Media
  • Careers
  • Investors
  • Contact

Delivering Therapy Where it Matters

4546 El Camino Real, Suite B1
Los Altos, CA 94022

(650) 284-4433

(650) 397-4433

Quicklinks
  • About
  • Clinical Trials
  • Our Therapy Platform
  • Pipeline Overview
  • Clinicians
  • News
  • Careers
  • Investors
  • Contact

© Copyright 2018-2025 RenovoRx®. All rights reserved. Site by Sheriar Designs.

Privacy Statement | Terms of Use

Menu